94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Yanbing Yang1†Xuenian Ye2†Haibin Zhang2Zhaowang Lin1Min Fang1Jian Wang1Yuyan Yu1Xuwen Hua1Hongxuan Huang2
Weifeng Xu3Ling Liu4*
Zhan Lin1*- 1Department of Radiology, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
- 2Department of Orthopedics, Dongguan People’s Hospital, Dongguan, China
- 3Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
- 4Department of Radiology, The First Affiliated Hospital of Dali University, Dali, China
A Corrigendum on
A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
by Yang Y, Ye X, Zhang H, Lin Z, Fang M, Wang J, Yu Y, Hua X, Huang H, Xu W, Liu L and Lin Z (2023). Front. Genet. 13:1068837. doi: 10.3389/fgene.2022.1068837
In the original article, there was a mistake in the Funding statement as published. The correct grant number for the Startup Fund for Scientific Research of Fujian Medical University is 2018QH1202. Corrected funding statement is given below:
“This work was supported by the Scientific Research Project for the Middle-aged and Youths of Fuzhou Health Department (grant number: 2019-S-wq9) and the Startup Fund for Scientific Research of Fujian Medical University (grant number: 2018QH1202).”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: transcription factor, high mobility group AT-hook protein 1, MAF BZIP transcription factor G, prognosis, therapeutic response, hepatocellular carcinoma
Citation: Yang Y, Ye X, Zhang H, Lin Z, Fang M, Wang J, Yu Y, Hua X, Huang H, Xu W, Liu L and Lin Z (2023) Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma. Front. Genet. 14:1146199. doi: 10.3389/fgene.2023.1146199
Received: 17 January 2023; Accepted: 18 January 2023;
Published: 25 January 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Yang, Ye, Zhang, Lin, Fang, Wang, Yu, Hua, Huang, Xu, Liu and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ling Liu, YW5kZHltYXJAc2luYS5jb20=; Zhan Lin, bGluemhhbm45NzdAMTYzLmNvbQ==
†These authors contributed equally to this work and share first authorship